Zacks Research Has Optimistic Opinion of Humana Q3 Earnings

Zacks Research has updated its earnings estimates for Humana (NYSE:HUM), raising its Q3 2026 EPS forecast to $(1.13) from $(1.18) and projecting fiscal 2026 EPS of $9.05, while maintaining a "Hold" rating. This optimistic revision follows Humana's latest quarter, where it exceeded expectations with EPS of $7.61 and revenue of $40.89 billion, a 26.2% year-over-year increase. Despite some mixed sentiment from other analysts, the consensus price target remains $408.61, with the company also declari